Laurion Capital Management’s Globus Medical GMED Stock Holding History

Laurion Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,294	Closed	-$226K	–	420
2024 Q2	$226K	Buy	+3,294	New	+$197K	﹤0.01%	465
2021 Q1	–	Sell	-7,395	Closed	-$482K	–	804
2020 Q4	$482K	Buy	+7,395	New	+$425K	﹤0.01%	489
2020 Q3	–	Sell	-5,985	Closed	-$286K	–	954
2020 Q2	$286K	Buy	+5,985	New	+$289K	﹤0.01%	732
2018 Q1	–	Sell	-22,359	Closed	-$919K	–	1456
2017 Q4	$919K	Sell	22,359 -58,183	-72%	-$2.04M	﹤0.01%	992
2017 Q3	$2.39M	Buy	80,542 +58,300	+262%	+$1.78M	0.01%	724
2017 Q2	$737K	Buy	+22,242	New	+$699K	﹤0.01%	1134
2015 Q4	–	Sell	-16,400	Closed	-$339K	–	938
2015 Q3	$339K	Buy	+16,400	New	+$415K	﹤0.01%	490

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Laurion Capital Management's GMED Position: Q3 2024 in Review

Laurion Capital Management sold out of Globus Medical (GMED) in Q3 2024, closing a stake of 3,294 shares — an estimated $226K sold.

Laurion Capital Management first reported a position in GMED in Q3 2015 and held it in 7 quarters. The position peaked at $2.39M in Q3 2017. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

Laurion Capital Management reported no remaining Globus Medical position as of Q3 2024 after selling out during the quarter.
Laurion Capital Management sold 3,294 Globus Medical shares in Q3 2024, an estimated $226K.
Laurion Capital Management first reported a position in Globus Medical in Q3 2015 and held it in 7 quarters.
Laurion Capital Management's Globus Medical position peaked at $2.39M in Q3 2017.
449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.